GLP-1s explained: How they work and potential trade-offs

SAN DIEGO — GLP-1 receptor agonists are a gamechanger in obesity care, but researchers are still working to better understand their effects, according to Vyvyane Loh, MD.At Obesity Medicine Association’s annual meeting, Loh — founder of Wellth-e, an educational platform focused on human performance medicine — offered attendees a deeper look at these medications.